Ms. Cardwell has provided Quality Assurance and Regulatory consulting for start-up cell therapy and biotechnology companies since 2005. Prior to August 2005 Ms. Cardwell held the position of Director of Regulatory Affairs and Quality Assurance at Xcyte Therapies. Through June of 2003 Ms. Cardwell was Vice-President for Quality Assurance and Quality Control at Dendreon Corporation. In the over 5 years at Dendreon she built and established departments to manage the quality systems required to manufacture test and release Cell Therapy products across different laboratories to release a class III (PMA) medical device and a recombinant protein.
|